Altimmune (NASDAQ: ALT) is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com. This is a high-visibility, high-impact role that will be critical to Altimmune's growth. Reporting to the Senior Director, Biostatistics, this individual will provide statistical leadership and serve as the lead statistician for one or more clinical development programs within Altimmune's pipeline. They will work collaboratively with clinical and development teams, including clinicians, clinical scientists, statistical programmers, data managers, regulatory, and clinical operations professionals, to plan, conduct, and analyze clinical studies of all phases. Responsible for the overall quality of statistical design, programming, analysis, and data reporting. Represents the company in interactions with outside statistical and data management service providers and participates in discussions with regulatory agencies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree